Read more about Jubilant Pharmova subsidiary to invest $92 mln for expansion on Business Standard. Jubilant Pharma, a wholly-owned subsidiary of Jubilant Pharmova, announced $92 million investment plans to expand sterile injectable manufacturing capacity at its Spokane site in Washington, US.
Read more about Jubilant Pharma to invest USD 92 mn for expansion of sterlite injectable manufacturing facility on Business Standard. At its Spokane site in Washington